ECMO支持患者胸腔引流管相关出血并发症
单中心观察性研究纳入2010至2024年因气胸或非出血性胸腔积液行胸腔引流的ECMO患者,分析胸腔引流管相关大出血的发生率、相关因素及对预后的影响。结果显示ECMO期间置管出血风险更高,出血患者ECMO支持时间更长且住院生存率更低。
要点
- ECMO患者胸腔引流管大出血发生率为12.5%(21/168例),8.1%(23/279根)引流管相关。
- ECMO支持期间置管出血率11.3%,高于ECMO前置管的4.7%(P=.036)。
- 出血患者ECMO支持时间更长(中位42 vs 17天,P=.003),住院生存率更低(47.6% vs 71.4%,P=.043)。
核心结论
- ECMO支持期间胸腔引流管相关大出血风险显著增加,尤其在插管后置管时。
- 发生出血并发症的患者住院时间更长且生存率更低。
研究设计与样本
- 单中心观察性研究,2010至2024年,纳入儿童和成人ECMO治疗期间因气胸或非出血性胸腔积液行胸腔引流的患者。
- 筛查1158例ECMO患者,168例(14.5%)需胸腔引流,共分析279根胸腔引流管。
主要发现
- 21例患者(12.5%)和23根引流管(8.1%)发生大出血,14例需开胸手术。
- ECMO支持期间置管出血率11.3%,高于ECMO前置管的4.7%(P=.036)。
- 出血患者ECMO支持时间中位42天 vs 17天(P=.003),住院生存率47.6% vs 71.4%(P=.043)。
- 出血与引流管尺寸、侧别、类型、置入技术或ECMO模式无关联,胸壁是最常见出血部位。
关键数值与推荐
- 大出血定义:按患者年龄调整的胸腔引流量、需多次红细胞输注或需外科干预。
临床怎么用
- ECMO患者置入胸腔引流管时应警惕大出血风险,尤其ECMO插管后置管者。
- 对发生胸腔引流管相关出血的ECMO患者,应关注延长支持时间和较低生存率的可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Bleeding is a common complication of extracorporeal membrane oxygenation (ECMO) support. While chest tube treatment is infrequently linked to bleeding in non-ECMO patients, several reports suggest a markedly increased risk during ECMO support, sometimes requiring surgical intervention. The true incidence, contributing factors, and effect on outcome from chest tube related bleeding in ECMO patients is unknown. METHODS: This was a single-centre observational study conducted between 2010 and 2024, including both paediatric and adult patients treated with chest tube for pneumothorax or non-haemorrhagic pleural fluid during their ECMO treatment. Major bleeding was defined by chest tube output amount adjusted to patient age, need for multiple red blood cell transfusions, or need for surgical intervention. RESULTS: Of the 1158 screened ECMO patients, 168 (14.5%) required chest drainage for pleural effusions or pneumothorax during the study period, and a total of 279 chest tubes were analysed. Major bleeding occurred in 21 patients (12.5%) and from 23 chest tubes (8.1%). Fourteen patients required thoracotomy. Bleeding was more common with tubes placed during ECMO support (11.3%) compared to pre-ECMO (4.7%, P = .036). Affected patients had longer ECMO durations (median 42 vs 17 days, P = .003) and lower hospital survival (47.6% vs 71.4%, P = .043). No associations were observed between bleeding and tube size, laterality, type, insertion technique, or ECMO mode. The chest wall was the most commonly identified bleeding location. CONCLUSIONS: There was a markedly increased risk of major bleeding from chest tubes during ECMO, particularly when inserted after cannulation. Patients who experienced bleeding complications had longer hospital stays and lower survival.
引用
- Dimberg A, Dalén M, Broman LM, et al. Bleeding Complications from Chest Tube Treatment in Patients on Extracorporeal Membrane Oxygenation Support. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 41273763. doi:10.1093/icvts/ivaf271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。